
Alpha Profiles · Company Profile
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States.
https://registry.alpha.ac/companies/lenz-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: LENZ
- Verification
- Partially verified
- Last reviewed
- 2026-10-14T04:46:51.317728+00:00
Overview
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-14T04:46:51.317728+00:00
